Asian Spectator

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Why Now Is the Perfect Time to Lease an Electric Vehicle?

Australia is seeing strong year on year growth of EVs, with government incentives, advancements in technology, and environmental awareness driving more people to consider electric vehicles. If you’ve...

Mengungkap manfaat tak terduga dari menjadi orang pelupa

Jangan putus asa!Asier RomeroLupa adalah bagian dari kehidupan kita sehari-hari. Kamu barangkali pernah masuk ke sebuah ruangan dan lupa alasan mengapa kamu masuk ke sana. Atau mungkin, seseorang meny...

‘Necro-branding’: Bisnis triliunan pernak-pernik mendiang artis

bissig/ShutterstockApakah kamu memiliki pernak-pernik legenda dunia yang sudah lama meninggal seperti Elvis Presley, Putri Diana, David Bowie, Prince, atau Michael Jackson? Ataupun legenda Indonesia s...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion